Return On Assets in % of Protara Therapeutics, Inc. from Q2 2015 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Protara Therapeutics, Inc. quarterly/annual Return On Assets history and change rate from Q2 2015 to Q3 2025.
  • Protara Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -32.5 %, a 33.8% increase year-over-year.
  • Protara Therapeutics, Inc. annual Return On Assets for 2024 was -40.1 %, a 8.58% increase from 2023.
  • Protara Therapeutics, Inc. annual Return On Assets for 2023 was -43.8 %, a 3.99% increase from 2022.
  • Protara Therapeutics, Inc. annual Return On Assets for 2022 was -45.6 %, a 77.4% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Protara Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -32.5 +16.6 +33.8% 01 Jul 2025 30 Sep 2025
Q2 2025 -33.9 +14.4 +29.9% 01 Apr 2025 30 Jun 2025
Q1 2025 -33.3 +18.1 +35.2% 01 Jan 2025 31 Mar 2025
Q4 2024 -40.1 +3.76 +8.58% 01 Oct 2024 31 Dec 2024
Q3 2024 -49.1 +19.5 +28.5% 01 Jul 2024 30 Sep 2024
Q2 2024 -48.3 +9.56 +16.5% 01 Apr 2024 30 Jun 2024
Q1 2024 -51.4 -2.25 -4.58% 01 Jan 2024 31 Mar 2024
Q4 2023 -43.8 +1.82 +3.99% 01 Oct 2023 31 Dec 2023
Q3 2023 -68.6 -45.2 -194% 01 Jul 2023 30 Sep 2023
Q2 2023 -57.8 -33.8 -140% 01 Apr 2023 30 Jun 2023
Q1 2023 -49.1 -23.8 -93.9% 01 Jan 2023 31 Mar 2023
Q4 2022 -45.6 -19.9 -77.4% 01 Oct 2022 31 Dec 2022
Q3 2022 -23.4 +0.6 +2.5% 01 Jul 2022 30 Sep 2022
Q2 2022 -24.1 -2.11 -9.6% 01 Apr 2022 30 Jun 2022
Q1 2022 -25.3 -2.59 -11.4% 01 Jan 2022 31 Mar 2022
Q4 2021 -25.7 -0.35 -1.38% 01 Oct 2021 31 Dec 2021
Q3 2021 -24 +9.25 +27.9% 01 Jul 2021 30 Sep 2021
Q2 2021 -22 +39.3 +64.1% 01 Apr 2021 30 Jun 2021
Q1 2021 -22.7 +48 +67.8% 01 Jan 2021 31 Mar 2021
Q4 2020 -25.4 +51.9 +67.2% 01 Oct 2020 31 Dec 2020
Q3 2020 -33.2 +34.1 +50.6% 01 Jul 2020 30 Sep 2020
Q2 2020 -61.2 +1.95 +3.09% 01 Apr 2020 30 Jun 2020
Q1 2020 -70.7 -3.89 -5.82% 01 Jan 2020 31 Mar 2020
Q4 2019 -77.3 -6.58 -9.31% 01 Oct 2019 31 Dec 2019
Q3 2019 -67.3 -6.25 -10.2% 01 Jul 2019 30 Sep 2019
Q2 2019 -63.2 +9.38 +12.9% 01 Apr 2019 30 Jun 2019
Q1 2019 -66.8 +4.95 +6.9% 01 Jan 2019 31 Mar 2019
Q4 2018 -70.7 +3.2 +4.33% 01 Oct 2018 31 Dec 2018
Q3 2018 -61 +16.6 +21.3% 01 Jul 2018 30 Sep 2018
Q2 2018 -72.5 -8.14 -12.6% 01 Apr 2018 30 Jun 2018
Q1 2018 -71.8 -10.1 -16.3% 01 Jan 2018 31 Mar 2018
Q4 2017 -73.9 -19.5 -35.9% 01 Oct 2017 31 Dec 2017
Q3 2017 -77.6 -29.9 -62.6% 01 Jul 2017 30 Sep 2017
Q2 2017 -64.4 -23.6 -57.9% 01 Apr 2017 30 Jun 2017
Q1 2017 -61.7 -28.1 -83.5% 01 Jan 2017 31 Mar 2017
Q4 2016 -54.4 -25.6 -89% 01 Oct 2016 31 Dec 2016
Q3 2016 -47.7 -37.8 -381% 01 Jul 2016 30 Sep 2016
Q2 2016 -40.8 -29.4 -257% 01 Apr 2016 30 Jun 2016
Q1 2016 -33.6 01 Jan 2016 31 Mar 2016
Q4 2015 -28.8 01 Oct 2015 31 Dec 2015
Q3 2015 -9.92 01 Jul 2015 30 Sep 2015
Q2 2015 -11.4 01 Apr 2015 30 Jun 2015

Protara Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -40.1 +3.76 +8.58% 01 Jan 2024 31 Dec 2024
2023 -43.8 +1.82 +3.99% 01 Jan 2023 31 Dec 2023
2022 -45.6 -19.9 -77.4% 01 Jan 2022 31 Dec 2022
2021 -25.7 -0.35 -1.38% 01 Jan 2021 31 Dec 2021
2020 -25.4 +51.9 +67.2% 01 Jan 2020 31 Dec 2020
2019 -77.3 -6.58 -9.31% 01 Jan 2019 31 Dec 2019
2018 -70.7 +3.2 +4.33% 01 Jan 2018 31 Dec 2018
2017 -73.9 -19.5 -35.9% 01 Jan 2017 31 Dec 2017
2016 -54.4 -25.6 -89% 01 Jan 2016 31 Dec 2016
2015 -28.8 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.